This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON

: NCT04503278 Comparison Group: Part 2 Vaccine-modulated - CLDN6 uRNA-LPX/CLDN6 modRNA-LPX

Raw json | Download

{
  "resourceType" : "Group",
  "id" : "mii-exa-mtb-study-cldn6-comparison-group-1",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: Group mii-exa-mtb-study-cldn6-comparison-group-1</b></p><a name=\"mii-exa-mtb-study-cldn6-comparison-group-1\"> </a><a name=\"hcmii-exa-mtb-study-cldn6-comparison-group-1\"> </a><p><b>type</b>: Person</p><p><b>actual</b>: false</p><h3>Characteristics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td><td><b>Exclude</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:\">Exposed to</span></td><td><a href=\"EvidenceVariable-mii-exa-mtb-study-cldn6-evidence-variable-1.html\">Biological: CLDN6 uRNA-LPX/CLDN6 modRNA-LPX</a></td><td>false</td></tr></table></div>"
  },
  "type" : "person",
  "actual" : false,
  "characteristic" : [
    {
      "code" : {
        "text" : "Exposed to"
      },
      "valueReference" : {
        🔗 "reference" : "EvidenceVariable/mii-exa-mtb-study-cldn6-evidence-variable-1",
        "display" : "Biological: CLDN6 uRNA-LPX/CLDN6 modRNA-LPX"
      },
      "exclude" : false
    }
  ]
}